What Is the Role of Dabrafenib Plus Trametinib Adjuvant Therapy in Stage IIIA Melanoma?
Author:
Affiliation:
1. Elif Hindié, MD, PhD, Bordeaux University Hospital, Bordeaux, France
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.18.02075
Reference10 articles.
1. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma
2. Adjuvant Dabrafenib plus Trametinib in Stage IIIBRAF-Mutated Melanoma
3. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
4. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
5. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adjuvante Anti‐PD‐1‐Antikörpertherapie bei Stadium‐III/IV‐Melanom: Anwendungsdaten aus der klinischen Routine und gesundheitsökonomische Aspekte;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-08
2. Adjuvant anti‐PD‐1 antibody treatment in stage III/IV melanoma: real‐world experience and health economic considerations;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-07-13
3. Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma;Journal of Clinical Oncology;2021-03-10
4. Sentinel Node Biopsy in Patients With Thin Melanoma: A Need to Better Define the Aim;Journal of Clinical Oncology;2020-09-20
5. Adjuvant and neoadjuvant treatment of melanoma;memo - Magazine of European Medical Oncology;2020-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3